FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157487785> ?p ?o ?g. }

• W3157487785 endingPage "499" @default.
• W3157487785 startingPage "490" @default.
• W3157487785 abstract "Esophageal cancer is the sixth most common cause of cancer-related mortality worldwide. Despite advances in diagnostic modalities and treatment options, five-year survival rates are below 20%. Esophagectomy with extended lymph node dissection is the mainstay of treatment. More than 50% of patients experience recurrence within 1-3 years postoperatively. Recurrent disease may present locoregionally at the site of anastomosis or as recurrence through lymphatic spread in lymph node basins, as hematogenic metastasis, or as a combination of these. The standard treatment of recurrence is currently predicated on systemic chemotherapy and/or radiotherapy. Recent evidence suggests that surgical treatment of metachronous oligometastatic disease may be prognostically advantageous over medical management alone. Given the considerably low response rates to chemoradiotherapy, many institutions have adopted surgical treatment strategies for oligo-recurrent disease on a case-by-case basis. The aim of this article is to review the current evidence on the role of surgical treatment for metachronous oligometastases from esophageal cancer. El cáncer de esófago es la sexta causa más frequente de mortalidad relacionada con el cáncer en todo el mundo. A pesar de los avances en los medios de diagnóstico y las opciones de tratamiento, la tasa de supervivencia a los cinco años es menor del 20%. La esofagectomía con la disección de ganglios linfáticos extendida es la base del tratamiento. Más del 50% de los pacientes experimentan recurrencia dentro de 1-3 años después de la operación. La enfermedad recurrente puede presentarse como recidiva locorregional en el sitio de la anastomosis o como recidiva a través de diseminación en los ganglios linfáticos, como metástasis hematológicas o como una combinación de todos ellos. El tratamiento estándar de la recidiva se basa actualmente en la quimioterapia sistémica y/o radioterapia. La evidencia reciente sugiere que el tratamiento quirúrgico de la enfermedad oligometastásica metacrónica puede tener ventajas pronósticas superiores al tratamiento exclusivamente médico. Dada la tasa de respuesta considerablemente baja a la quimiorradioterapia, muchas instituciones han adoptado estrategias de tratamiento quirúrgico para la enfermedad oligorrecurrente caso por caso. El objetivo de este artículo es revisar la evidencia actual sobre el papel del tratamiento quirúrgico de las oligometástasis metacrónicas del cáncer de esófago." @default.
• W3157487785 created "2021-05-10" @default.
• W3157487785 creator A5001610177 @default.
• W3157487785 creator A5020318920 @default.
• W3157487785 creator A5021896070 @default.
• W3157487785 creator A5029062865 @default.
• W3157487785 creator A5037287384 @default.
• W3157487785 creator A5061377665 @default.
• W3157487785 creator A5069496420 @default.
• W3157487785 creator A5087953432 @default.
• W3157487785 date "2021-08-01" @default.
• W3157487785 modified "2023-10-16" @default.
• W3157487785 title "Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence?" @default.
• W3157487785 cites W1594731676 @default.
• W3157487785 cites W1818747732 @default.
• W3157487785 cites W1891507428 @default.
• W3157487785 cites W1969152636 @default.
• W3157487785 cites W1970002789 @default.
• W3157487785 cites W1970546230 @default.
• W3157487785 cites W1972068191 @default.
• W3157487785 cites W1976794235 @default.
• W3157487785 cites W1986004613 @default.
• W3157487785 cites W1987357850 @default.
• W3157487785 cites W1990715504 @default.
• W3157487785 cites W2005613543 @default.
• W3157487785 cites W2015159485 @default.
• W3157487785 cites W2017421413 @default.
• W3157487785 cites W2021707091 @default.
• W3157487785 cites W2025049380 @default.
• W3157487785 cites W2032942936 @default.
• W3157487785 cites W2039969544 @default.
• W3157487785 cites W2047352375 @default.
• W3157487785 cites W2047663691 @default.
• W3157487785 cites W2062341497 @default.
• W3157487785 cites W2063923512 @default.
• W3157487785 cites W2066596225 @default.
• W3157487785 cites W2069365519 @default.
• W3157487785 cites W2074672770 @default.
• W3157487785 cites W2082262885 @default.
• W3157487785 cites W2102748422 @default.
• W3157487785 cites W2106023881 @default.
• W3157487785 cites W2149022053 @default.
• W3157487785 cites W2159799895 @default.
• W3157487785 cites W2174629529 @default.
• W3157487785 cites W2233177539 @default.
• W3157487785 cites W2264241948 @default.
• W3157487785 cites W2333298450 @default.
• W3157487785 cites W2517506528 @default.
• W3157487785 cites W2522320540 @default.
• W3157487785 cites W2538699392 @default.
• W3157487785 cites W2543239575 @default.
• W3157487785 cites W2567821400 @default.
• W3157487785 cites W2569169810 @default.
• W3157487785 cites W2605981369 @default.
• W3157487785 cites W2620877099 @default.
• W3157487785 cites W2728044047 @default.
• W3157487785 cites W2739569008 @default.
• W3157487785 cites W2775807676 @default.
• W3157487785 cites W2779737238 @default.
• W3157487785 cites W2780574400 @default.
• W3157487785 cites W2781341811 @default.
• W3157487785 cites W2781622562 @default.
• W3157487785 cites W2794787607 @default.
• W3157487785 cites W2800354923 @default.
• W3157487785 cites W2901927935 @default.
• W3157487785 cites W2912182053 @default.
• W3157487785 cites W2913434006 @default.
• W3157487785 cites W2913904891 @default.
• W3157487785 cites W2916300128 @default.
• W3157487785 cites W2941031014 @default.
• W3157487785 cites W2943869142 @default.
• W3157487785 cites W2944441623 @default.
• W3157487785 cites W2960911471 @default.
• W3157487785 cites W2963749089 @default.
• W3157487785 cites W2972374526 @default.
• W3157487785 cites W2984577809 @default.
• W3157487785 cites W2997887548 @default.
• W3157487785 cites W2998427152 @default.
• W3157487785 cites W3014571611 @default.
• W3157487785 cites W3093889019 @default.
• W3157487785 cites W4252560545 @default.
• W3157487785 doi "https://doi.org/10.1016/j.ciresp.2021.03.003" @default.
• W3157487785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34353590" @default.
• W3157487785 hasPublicationYear "2021" @default.
• W3157487785 type Work @default.
• W3157487785 sameAs 3157487785 @default.
• W3157487785 citedByCount "0" @default.
• W3157487785 crossrefType "journal-article" @default.
• W3157487785 hasAuthorship W3157487785A5001610177 @default.
• W3157487785 hasAuthorship W3157487785A5020318920 @default.
• W3157487785 hasAuthorship W3157487785A5021896070 @default.
• W3157487785 hasAuthorship W3157487785A5029062865 @default.
• W3157487785 hasAuthorship W3157487785A5037287384 @default.
• W3157487785 hasAuthorship W3157487785A5061377665 @default.
• W3157487785 hasAuthorship W3157487785A5069496420 @default.
• W3157487785 hasAuthorship W3157487785A5087953432 @default.
• W3157487785 hasConcept C121608353 @default.
• W3157487785 hasConcept C126322002 @default.

• next